Bristol-Myers Squibb’s Stock Looks Cheap on the Surface, but Hidden Risks Lurk Beneath

Life Science

Healthcare ETF Face-off: VHT, IXJ and XBI – Which Fits Your Portfolio?

Life Science

This Health Insurance Company Is Approaching Its Profit Inflection Point

Life Science

5 Institutional-Approved High-Dividend Pharmaceutical Stocks for Passive Income Investors

Life Science

After the Market Pullback, the Defensive Value of Two Blue-Chip Stocks Stands Out

Life Science, Technology

Riding on Strong Earnings and a $1.5 Billion Market Catalyst, Exelixis Is Poised for Takeoff

Life Science

CVS Stock Soars 107%: Steady Dividends Power Its Impressive Turnaround

Life Science

Is It Wise to Follow the Herd and Buy the Same Weight-Loss Drug Giant as the U.S. President?

Life Science

Billionaires Reduce Holdings in UnitedHealth, Yet Wall Street Remains Bullish

Life Science

Wall Street’s Big UNH Split: Berkshire Exits, Goldman Sees Solid Upside

Life Science

Teladoc Health’s Stock Plunges Over 90% as Market Questions Its Dominance

Life Science

Translating 10 Projects Weekly, Eli Lilly Launches Largest Acquisition Wave in Its History

Life Science

Beyond Lilly and Novo Nordisk: Two Under-the-Radar Picks in the Obesity Drug Market

Life Science

Is Pfizer’s Stock, with a Dividend Yield Exceeding 6%, Undervalued by the Market?

Life Science

These Three Disruptive Stocks Are Poised to Deliver Massive Returns Over the Next Two Decades

Life Science, Technology